Summary Background Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine
threatens the antimalarial effectiveness of intermittent preventive treatment during …

Background While traditional epidemiological approaches have supported significant
reductions in malaria incidence across many countries, higher resolution information about …

Background Sulfadoxine–pyrimethamine (SP) is recommended for intermittent preventive
treatment of malaria in Africa. However, increasing SP resistance (SPR) affects the …

Abstract Background Increasing resistance of Plasmodium falciparum to sulfadoxine-
pyrimethamine (SP) threatens its usefulness for intermittent preventive treatment in …

Abstract Background Point mutations in Plasmodium falciparum dihydrofolate reductase
(Pfdhfr) and dihydropteroate synthase (Pfdhps) genes which confer resistance to …

Sulfadoxine-pyrimethamine (SP) resistance impairs the efficacy of antimalarial drugs.
Monitoring molecular markers in exported malaria infections provides an efficient way to …

Malaria is an age-old disease of human kind living in the tropical and sub-tropical regions of
the globe, with Africa contributing the highest incidence of morbidity and mortality. Among …

Objectives Partial artemisinin resistance, mediated by Plasmodium falciparum K13 (PfK13)
mutations, has been confirmed in certain areas of East Africa that are historically associated …

Objectives This study investigated the prevalence of haplotypes of the Pfdhps, Pfdhfr, Pfcrt,
Pfmdr1 and PfK13 resistance markers in isolates from asymptomatic patients from the …

Background The study was conducted to investigate malaria prevalence among a group of
women in the Democratic Republic of Congo (DRC) who received intermittent preventive …